177 related articles for article (PubMed ID: 28551519)
1. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery.
Chantaburanan T; Teeranachaideekul V; Chantasart D; Jintapattanakit A; Junyaprasert VB
J Colloid Interface Sci; 2017 Oct; 504():247-256. PubMed ID: 28551519
[TBL] [Abstract][Full Text] [Related]
2. Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.
Chantaburanan T; Teeranachaideekul V; Jintapattanakit A; Chantasart D; Junyaprasert VB
Int J Pharm X; 2023 Dec; 6():100205. PubMed ID: 37609107
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.
Jensen LB; Magnussson E; Gunnarsson L; Vermehren C; Nielsen HM; Petersson K
Int J Pharm; 2010 May; 390(1):53-60. PubMed ID: 19836439
[TBL] [Abstract][Full Text] [Related]
5. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
6. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
7. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
8. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
10. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
11. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
[TBL] [Abstract][Full Text] [Related]
12. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes.
Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK
Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of solid lipid nanoparticles containing peptide.
Hu FQ; Hong Y; Yuan H
Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
16. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J
Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048
[TBL] [Abstract][Full Text] [Related]
17. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.
Wen LX; Ding HM; Wang JX; Chen JF
J Nanosci Nanotechnol; 2006; 6(9-10):3139-44. PubMed ID: 17048529
[TBL] [Abstract][Full Text] [Related]
18. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.
Rahman MA; Harwansh RK; Iqbal Z
Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786
[TBL] [Abstract][Full Text] [Related]
19. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]